SCHEMBL24676918

SCHEMBL24676918

CC(C)CC12CCC1CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22852013 0.73 SLC6A2 (0.40)
SCHEMBL17033032 0.63 JAK2 (0.33)
SCHEMBL15534431 0.63 CYP2D6 (0.31)
SCHEMBL19011624 0.63
SCHEMBL24758263 0.63 PIK3CD (0.34)
SCHEMBL24302279 0.62
SCHEMBL15533538 0.61 CYP2D6 (0.31)
SCHEMBL31566769 0.60
SCHEMBL15891572 0.60 CYP2D6 (0.33)
SCHEMBL20147352 0.60 CYP2D6 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129780-A1 BENZIMIDAZOLE DERIVATIVES AS GPX4 INHIBITORS SONATA THERAPEUTICS, INC. (US) 2024-06-20 WO disclosed
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed